Brain Death Clinical Trial
Official title:
Tissue Oxygen Saturation During Management of the Deceased by Neurological Criteria Organ Donor as a Predictor of Number of Organs to Transplant Per Donor
The objective of this study is to quantify the association between tissue oxygen saturation (StO2) during the donor management phase of the Death by Neurological Criteria (DNC) organ donor and the number of organs transplanted per donor.
Specifically the study aims to:
1. Evaluate the association between StO2 level in the DNC organ donor and the number of
organs transplanted per donor;
2. Evaluate whether or not tissue perfusion in the DNC organ donor population correlates
with currently measured macro-hemodynamic variables during the donor management phase.
3. Assess if StO2 in the DNC organ donor is related to the number of organs with normal
end-organ function, and with the number of organs predicted to be transplanted using
the organ donor calculator.
4. Assess if StO2 in the DNC organ donor is related with intravenous thyroid hormone
treatment.
Investigators will conduct an observational study, including 60 DNC organ donors, in
Lifebanc's Donor Service Area (DSA). Investigators will monitor and record blindly the StO2
with near-infrared spectroscopy (NIRS) in the DNC organ donor from the beginning of the OPO
(Organ Procurement Organization) organ donor management period until cardiac arrest in the
operating room at the time of recovery.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03765814 -
The Anticipated Organ Donation Approach
|
||
Completed |
NCT02581111 -
Naloxone for Optimizing Hypoxemia Of Lung Donors
|
Phase 2/Phase 3 | |
Completed |
NCT00808691 -
Microcirculation and Oxidative Stress in Critical Ill Patients in Surgical Intensive Care Unit
|
N/A | |
Completed |
NCT00998972 -
N-acetyl-cysteine (NAC) and Kidney Graft Function
|
Phase 3 | |
Completed |
NCT04528797 -
Thyroid and Adrenocortical Hormone Replacement in Organ Donors
|
N/A | |
Completed |
NCT03672812 -
The Use of Liraglutide in Brain Death
|
Phase 3 | |
Completed |
NCT04303624 -
Understanding Family Refusal
|
||
Completed |
NCT03098706 -
Therapeutic Hypothermia in "Expanded Criteria" Brain-dead Donors and Kidney-graft Function
|
N/A | |
Not yet recruiting |
NCT04623294 -
Online Noninvasive Assessment of Human Brain Death and Deep Coma by Near-infrared Spectroscopy
|
||
Recruiting |
NCT02102945 -
Special Imaging Technique to Aid in the Diagnosis of Patients in Coma After Cardiac Arrest
|
N/A | |
Completed |
NCT02483273 -
Alterations of Conjunctival Microcirculation in Brain Dead Patients
|
N/A | |
Terminated |
NCT00675272 -
Organ Donation and Hydrocortisone Treatment
|
N/A | |
Completed |
NCT03262896 -
Neurophysiological Examination in Patients With Brain Death
|
||
Not yet recruiting |
NCT06359119 -
Implementation of Apnoea Test for Patients With Suspected Brain Death
|
||
Recruiting |
NCT05202886 -
"LiverColor": Machine Learning in Liver Photographs
|
N/A | |
Completed |
NCT03281993 -
Apnea Tests as the Methods of Brain Death Diagnosis.
|
N/A | |
Completed |
NCT03179020 -
Donation Network to Optimize Organ Recovery Study
|
N/A | |
Completed |
NCT05070182 -
Resting Energy Needs in Brain Dead Patients (reSting EneRgy nEeds iN brAin DEad Patients)
|
||
Terminated |
NCT03439995 -
Goal of Open Lung Ventilation in Donors
|
N/A | |
Completed |
NCT02525510 -
Deceased Organ Donor Interventions to Protect Kidney Graft Function
|
N/A |